Details for New Drug Application (NDA): 206716
✉ Email this page to a colleague
NDA 206716 describes MAFENIDE ACETATE, which is a drug marketed by Ingenus Pharms Llc and Ph Health and is included in two NDAs. Additional details are available on the MAFENIDE ACETATE profile page.
The generic ingredient in MAFENIDE ACETATE is mafenide acetate. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the mafenide acetate profile page.
The generic ingredient in MAFENIDE ACETATE is mafenide acetate. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the mafenide acetate profile page.
Summary for 206716
| Tradename: | MAFENIDE ACETATE |
| Applicant: | Ingenus Pharms Llc |
| Ingredient: | mafenide acetate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 206716
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;TOPICAL | Strength | 5% | ||||
| Approval Date: | Jul 31, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
